Non-invasive continuous glucose monitoring (CGM) systems offer the advantage of non-invasive, real-time dynamic glucose monitoring, marking a significant advancement in diabetes management. However, the complexity of their sensing principles and operational mechanisms make systems vulnerable to various factors, which may introduce measurement bias or cause system interruptions and thereby compromise patient safety and monitoring effectiveness. To address these challenges, the Design Failure Mode and Effects Analysis (DFMEA) method is employed to identify and prioritize risks by assigning expert-based scores to critical components, ultimately enabling targeted improvements for high-risk failu... More >